DARS1-AS1 and hepatocellular carcinoma: This regulatory mechanism of miR-3200-5p is competitively inhibited by DARS-AS1 and targets the cytoskeleton-associated protein 2 (CKAP2) to aggravate the growth and invasion of hepatocellular carcinoma [38].